BridgeMD
New treatment option for Somatic Symptom Disorder (DSM-5)
Official title An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom Disorder
ClinicalTrials.gov ID: NCT07646509
What this study is testing
- What it's testing
- Persistent somatic symptoms significantly impair the daily lives of individuals with Somatic Symptom Disorder (SSD). Negative psychological factors (NPFs), such as catastrophizing and negative affectivity, further compound this impairment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Somatic Symptom Disorder
You likely can't join if
- chronic physical illnesses that fully explain the somatic symptoms
- current psychotic disorder
- current bipolar disorder
- current self-harming behavior
- current suicidality
- current psychotherapy
See the full eligibility criteria
- Somatic Symptom Disorder
- chronic physical illnesses that fully explain the somatic symptoms
- current psychotic disorder
- current bipolar disorder
- current self-harming behavior
- current suicidality
- current psychotherapy
- alcohol, drug, or medication dependence within the past 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Vienna, State of Vienna, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vienna, State of Vienna, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.